Chris Batchelor

Chris Batchelor is the CEO of Enviroinvest. He is an experienced leader and investment expert having worked in financial markets for over 25 years. This includes co-founding a stock market research business and running it for seven years until it was sold. He is qualified as a Chartered Financial Analyst and holds a Graduate Diploma of Applied Finance and Investment and Bachelor of Commerce Degree. He has been a regular contributor to Money since 2012. Connect with Chris on LinkedIn.


98 results for Chris Batchelor:

Should you buy, hold or sell Dicker Data shares?

Dicker Data shares fell 10% this week after founder David Dicker sold 10.2% of shares following a divorce settlement, so what does that mean for shareholders?

Should you buy, hold or sell GWA Group shares?

Haven't heard of the GWA Group? You're probably more familiar with what it makes - Caroma, Methven, and Clark and Dorf bathroom accessories.

Should you buy, hold or sell GrainCorp shares?

GrainCorp surprised the market with a better-than-expected result late last year, so what does 2024 hold for the agribusiness giant?

Should you buy, hold or sell shares in Seven Group?

Caterpillar backhoes and excavators are not the first thing most people think about when they think of Kerry Stokes' Seven Group.

Should you buy, hold or sell Computershare stocks?

Australian investors often like to find good income stocks, that is, stocks that pay a good dividend, ideally fully franked.

What is the forecast for AMP shares?

There have been some brief periods of cheer for AMP shareholders, but for the most part, things have been grim. And then came the royal commission.

Is Carsales a good investment?

Carsales has grown its revenue from $100 million in 2007 to $942 million today, so what does the future hold?

Why you should consider buying Bapcor shares

So you haven't heard of Bapcor? You're probably familiar with some of its brands, and you likely benefit from its business.

Is now the time to buy shares in McMillan Shakespeare?

McMillan Shakespeare's share price has risen by 37% since January, but can the company continue its strong run?

A healthy outlook for Sonic Healthcare shares

Sonic Healthcare is the largest operator of pathology labs in Australia with 37% of the market share, so why did the share price dip 10% in February?
1 2 3 4 … 10